In the unending war against cancer, few adversaries have proven as stubbornly resilient as chemoresistance in lung malignancies. For decades,...

The relentless adaptability of solid tumors has long confounded researchers, and nowhere is this more apparent than in the chimeric...

In a sweeping analysis of over 2.4 million cancer cases across the United States, researchers have uncovered a stark and...

A rogue population of immune cells, long overlooked in the complex landscape of the human gut, has been unmasked as...

In the labyrinthine ecosystem of a growing tumor, not all cellular residents are sworn enemies. Macrophages, the immune system’s versatile...

In a groundbreaking advancement for cancer immunotherapy, a team of researchers has unveiled promising results from a phase Ib clinical...

In the relentless pursuit of personalized cancer treatment, a groundbreaking artificial intelligence (AI) model named COMPASS is setting a new...

Colorectal cancer (CRC) remains one of the most significant causes of cancer-related mortality worldwide, with liver metastases representing a chief...

In recent years, the Apelin–APLNR pathway has emerged as a crucial regulator of vascular biology, particularly within the lung microenvironment....

On July 1, 2026, a significant advancement was announced in the realm of clinical cancer research with the appointment of...